Calcitonin-salmon

— THERAPEUTIC CATEGORIES —
  • Bone disorders

Calcitonin-salmon Generic Name & Formulations

General Description

Calcitonin-salmon (rDNA origin) 200 IU/spray; nasal spray.

Pharmacological Class

Hormone.

How Supplied

Contact supplier.

Calcitonin-salmon Indications

Indications

Postmenopausal osteoporosis.

Limitations of Use

Not shown to increase BMD in early postmenopausal women.

Calcitonin-salmon Dosage and Administration

Adult

1 spray (200Units) in alternating nostrils daily.

Children

Not applicable.

Calcitonin-salmon Contraindications

Not Applicable

Calcitonin-salmon Boxed Warnings

Not Applicable

Calcitonin-salmon Warnings/Precautions

Warnings/Precautions

Correct hypocalcemia and other disorders (eg, Vit. D deficiency) prior to initiating; monitor serum calcium during therapy. Supplement diet with calcium (1g/day) and Vit. D (400 IU/day); reevaluate periodically. Seizures. Do periodic nasal exams; discontinue if severe nasal ulceration occurs. Increased risk of malignancies. Pregnancy (Cat.C), nursing mothers: not recommended.

Calcitonin-salmon Pharmacokinetics

See Literature

Calcitonin-salmon Interactions

Interactions

May antagonize lithium; adjust dose.

Calcitonin-salmon Adverse Reactions

Adverse Reactions

Rhinitis, epistaxis, other nasal symptoms, back pain, arthralgia, headache; hypersensitivity reactions, antibody formation.

Calcitonin-salmon Clinical Trials

See Literature

Calcitonin-salmon Note

Notes

Formerly known under the brand name Fortical or Miacalcin.

Calcitonin-salmon Patient Counseling

See Literature